VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.0%
5Y CAGR+29.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.0%/yr
vs +24.6%/yr prior
5Y CAGR
+29.9%/yr
Recent deceleration
Acceleration
-18.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $70.33M | +24.6% |
| 2025 | $56.46M | +65.6% |
| 2024 | $34.09M | -42.3% |
| 2023 | $59.04M | +20.8% |
| 2022 | $48.89M | +157.0% |
| 2021 | $19.02M | -4.3% |
| 2020 | $19.87M | -19.0% |
| 2019 | $24.53M | +72.8% |
| 2018 | $14.20M | +23.5% |
| 2017 | $11.50M | - |